NEW FILINGS
Company: Amylyx Pharmaceuticals, Inc.
Symbol: AMLX (Nasdaq)
Description: Their mission is to develop therapies that change the treatment paradigm for amyotrophic lateral sclerosis, or ALS, and a broad range of neurodegenerative diseases by keeping neurons alive.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Goldman Sachs, SVB Leerink, Evercore ISI
Co-Manager(s): HC Wainwright
Link to Prospectus: Filed: 12-17-21
Listed Cash Raise: $100m
Company: CinCor Pharma, Inc.
Symbol: CINC (Nasdaq)
Description: They are a clinical-stage biopharmaceutical company focused on developing our lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Morgan Stanley, Jefferies, Evercore ISI
Co-Manager(s): Oppenheimer
Link to Prospectus: Filed: 12-17-21
Listed Cash Raise: $100m
Company: TPG Inc.
Symbol: TPG (Nasdaq)
Description: They are a leading global alternative asset manager with approximately $109 billion in assets under management as of September 30, 2021.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: J.P. Morgan, Goldman Sachs, Morgan Stanley, TPG Capital, BofA Securities, Citigroup, Deutsche Bank Securities, Evercore ISI, UBS Investment Bank, Wells Fargo Securities, BMO Capital Markets, Barclays
Co-Manager(s): Mizuho Securities, Keefe Bruyette & Woods, MUFG, SMBC Nikko, AmeriVet Securities, Blaylock Van, C.L. King & Associates, Drexel Hamilton, R. Seelaus & Co., Ramirez & Co., Siebert Williams Shank
Link to Prospectus: Filed: 12-16-21
Listed Cash Raise: $100m
Company: Justworks, Inc.
Symbol: JW (Nasdaq)
Description: Justworks is a cloud-based software platform that gives small and medium-sized businesses (“SMBs”) access to benefits, payroll, human resources (“HR”), and compliance support—all in one place.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Goldman Sachs, J.P. Morgan, BofA Securities
Co-Manager(s): Baird, Piper Sandler, Raymond James, Stifel, William Blair, Siebert Williams Shank
Link to Prospectus: Filed: 12-16-21
Listed Cash Raise: $100m